@article{JTD20441,
author = {Wenhua Liang and Yi Zhao and Weizhe Huang and Hengrui Liang and Haikang Zeng and Jianxing He},
title = {Liquid biopsy for early stage lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 7},
year = {2018},
keywords = {},
abstract = {Liquid biopsy, which analyzes biological fluids especially blood specimen to detect and quantify circulating cancer biomarkers, have been rapidly introduced and represents a promising potency in clinical practice of lung cancer diagnosis and prognosis. Unlike conventional tissue biopsy, liquid biopsy is non-invasive, safe, simple in procedure, and is not influenced by manipulators’ skills. Notably, some circulating cancer biomarkers are already detectable in disease with low-burden, making liquid biopsy feasible in detecting early stage lung cancer. In this review, we described a landscape of different liquid biopsy methods by highlighting the rationale and advantages, accessing the value of various circulating biomarkers and discussing their possible future development in the detection of early lung cancer.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/20441}
}